Preview

Медицинский Совет

Расширенный поиск

Запоры нужно лечить

https://doi.org/10.21518/2079-701X-2018-14-61-66

Полный текст:

Аннотация

В статье представлены этиология, патофизиология, эпидемиология запоров. Описаны основные группы лекарственных препаратов, которые применяются при лечении запоров. Стимулирующие слабительные средства чаще других востребованы пациентами. Представлен анализ использования пикосульфата натрия в различных клинических исследованиях. Пикосульфат натрия – один из основных препаратов из группы стимулирующих слабительных.

Об авторах

Е. Ю. Плотникова
ФГБОУ ВО «Кемеровский государственный медицинский университет» Минздрава России
Россия

д.м.н., профессор кафедры подготовки врачей первичного звена здравоохранения, руководитель курса клинической гастроэнтерологии,

Кемерово



К. А. Краснов
ФГБОУ ВО «Кемеровский государственный медицинский университет» Минздрава России
Россия

к.м.н., доцент кафедры госпитальной хирургии,

Кемерово



Список литературы

1. Pare P, Ferrazzi S, Thompson WG, Irvine EJ, Rance L. An epidemiological survey of constipation in canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol, 2001 Nov, 96(11): 3130-7.

2. Higgins PD, Johanson JF. Epidemiology of constipation in North America: A systematic review. Am J Gastroenterol, 2004, 99: 750–9.

3. Wald A, Scarpignato C, Mueller-Lissner S, et al. A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther, 2008, 28: 917–30.

4. Tack J, Muller-Lissner S. Treatment of chronic constipation: Current pharmacologic approaches and future directions. Clin Gastroenterol Hepatol, 2009, 7: 502–8.

5. Leung L, Riutta T, Kotecha J, Rosser W. Chronic constipation: an evidence-based review. J Am Board Fam Med, 2011, 24(4): 436–51.

6. Kurniawan I, Simadibrata M. Management of chronic constipation in the elderly. Acta Med Indones, 2011, 43(3): 195–205.

7. Sanchez MI, Bercik P. Epidemiology and burden of chronic constipation. Can J Gastroenterol, 2011, 25: 11B-L 15B.

8. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Cumulative incidence of chronic constipation: a population-based study 1988–2003. Aliment Pharmacol Ther, 2007, 26(11–12): 1521–1528.

9. Bytzer P, Howell S, Leemon M, et al. Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults. Gut, 2001, 49: 66–72.

10. Sandler RS, Jordan MC, Shelton BJ. Demographic and dietary determinants of constipation in the US population. Am J Public Health, 1990, 80: 185–9.

11. Inan M, Aydiner CY, Tokuc B, et al. Factors associated with childhood constipation. J Paediatr Child Health, 2007, 43: 700–6.

12. Ip KS, Lee WT, Chan JS, et al. A communitybased study of the prevalence of constipation in young children and the role of dietaryfibre. Hong Kong Med J, 2005, 11: 431–6.

13. Ludvigsson JF. Abis Study Group. Epidemiological study of constipation and other gastrointestinal symptoms in 8000 children. Acta Paediatr, 2006, 95: 573–80.

14. Talley NJ, Fleming KC, Evans JM, et al. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol, 1996, 91(1): 19–25.

15. Bongers ME, Benninga MA, Maurice-Stam H, Grootenhuis MA. Health-related quality of life in young adults with symptoms of constipation continuing from childhood into adulthood. Health Qual Life Outcomes, 2009, 7: 20.

16. Wang JP, Duan LP, Ye HJ, Wu ZG, Zou B. Assessment of psychological status and quality of life in patients with functional constipation. Zhonghua Nei Ke Za Zhi, 2008, 47(6): 460–463. Chinese.

17. Irvine EJ, Ferrazzi S, Pare P, Thompson WG, Rance L. Health-related quality of life in functional GI disorders: Focus on constipation and resource utilization. Am J Gastroenterol, 2002, 97: 1986–3.

18. Belsey J, Greenfield S, Candy D, Geraint M. Systematic review: impact of constipation on quality of life in adults and children. Send to Aliment Pharmacol Ther, 2010 May, 31(9): 938- 49.

19. Paré P, Bridges R, Champion MC, Ganguli SC, Gray JR, Irvine EJ, Plourde V, Poitras P, Turnbull GK, Moayyedi P, et al. Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment. Can J Gastroenterol, 2007, 21(Suppl B): 3B–22B.

20. Bharucha AE. Constipation. Best Pract Res Clin Gastroenterol, 2007, 21(4): 709-31.

21. Gonlachanvit S, Patcharatrakul T. Causes of idiopathic constipation in Thai patients: associations between the causes and constipation symptoms as defined in the Rome II criteria. J Med Assoc Thai, 2004, 87(2): 22–S28.

22. Chatoor D, Emmnauel A. Constipation and evacuation disorders. Best Pract Res Clin Gastroenterol, 2009, 23(4): 517-30.

23. Krogh K, Christensen P, Laurberg S. Colorectal symptoms in patients with neurological diseases. Acta Neurol Scand, 2001, 103: 335–43.

24. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care, 2003, 26: 1553–79.

25. Kessmann J. Hirschsprung’s disease: diagnosis and management. Am Fam Physician, 2006, 74: 1319–22.

26. Peters HP, De Vries WR, Vanberge-Henegouwen GP, Akkermans LM. Potential benefits and hazards of physical activity and exercise on the gastrointestinal tract. Gut, 2001, 48: 435–9.

27. Talley NJ, Jones M, Nuyts G, Dubois D. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol, 2003, 98: 1107–11.

28. Плотникова Е.Ю., Золотухина В.Н., Грачева Т.Ю. Место стимулирующих слабительных средств в терапии запоров. Медицинский совет, 2016, 7: 100-106. /Plotnikova EYu, Zolotukhina VN, Gracheva TYu. The role of stimulant laxatives in the management of constipation. Meditsinsky Sovet, 2016, 7: 100-106

29. Wald A. Constipation in elderly patients. Pathogenesis and management. Drugs Aging, 1993, 3: 220–31.

30. Chang L, Toner BB, Fukudo S, et al. Gender, age, society, culture, and the patient’s perspective in the functional gastrointestinal disorders. Gastroenterology, 2006, 130: 1435–46.

31. Forootan M, Bagheri N, Darvishi M. Chronic constipation. A review of literature. Medicine (Baltimore), 2018 May, 97(20): e10631.

32. Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology, 2016, 150: 1393–1407.

33. Bharucha AE, Dorn SD, Lembo A, Pressman A. American Gastroenterological Association medical position statement on constipation. Gastroenterology, 2013, 144: 211–217.

34. Costilla VC, Foxx-Orenstein AE. Constipation in adults: diagnosis and management. Curr Treat Options Gastroenterol, 2014, 12: 310–321.

35. De Schryver AM, Samsom M, Smout AI. Effects of a meal and bisacodyl on colonic motility in healthy volunteers and patients with slowtransit constipation. Dig Dis Sci, 2003, 48: 1206–1212.

36. Villoria A, Serra J, Azpiroz F, Malagelada JR. Physical activity and intestinal gas clearance in patients with bloating. Am J Gastroenterol, 2006, 101: 2552–2557.

37. Sikirov D. Comparison of straining during defecation in three positions: results and implications for human health. Dig Dis Sci, 2003, 48: 1201–1205.

38. Muller-Lissner SA, Kamm MA, Scarpignato C, Wald A. Myths and misconceptions about chronic constipation. Am J Gastroenterol, 2005, 100: 232–242.

39. Basilisco G, Coletta M. Chronic constipation: a critical review. Dig Liver Dis, 2013, 45: 886–93.

40. Rutter K, Maxwell D. Diseases of the alimentary system. Constipation and laxative abuse. BMJ, 1976, 2: 997–1000.

41. Smith B. Pathologic changes in the colon produced by anthraquinone purgatives. Dis Colon Rectum, 1973, 16: 455–8.

42. Smith B. Effect of irritant purgatives on the myenteric plexus in man and the mouse. Gut, 1968, 9: 139–43.

43. Dufour P, Gendre P. Ultrastructure of mouse intestinal mucosa and changes observed after long term anthraquinone administration. Gut, 1984, 25: 1358–63.

44. Bharucha AE, Pemberton JH, Locke GRI. American Gastroenterological Association technical review on constipation. Gastroenterology, 2013, 144: 218–38.

45. Kiernan JA, Heinicke EA. Sennosides do not kill myenteric neurons in the colon of the rat or mouse. Neuroscience, 1989, 30: 837–42. 46. Bosshard W, Dreher R, Schnegg J, Bula C. The treatment of chronic constipation in elderly people: an update. Drugs Aging, 2004, 21: 911- 930.

46. Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: Systematic review and metaanalysis. Gut, 2011, 60: 209–18.

47. Аптечные продажи слабительных средств. Московские аптеки (фармацевтическая газета), 2013. http://mosapteki.ru/material/aptechnyeprodazhi-slabitelnyx-sredstv-1386

48. Электронная энциклопедия лекарств и товаров аптечного ассортимента. http: //www.rlsnet.ru/mnn_index_id_1726.htm

49. Bengtsson M, Ohlsson B. Retrospective study of long-term treatment with sodium picosulfate. Eur J Gastroenterol Hepatol, 2004, 16: 433-434.

50. Hinkel U, Schuijt C, Erckenbrecht JF. OTC laxative use of sodium picosulfate â results of a pharmacy-based patient survey (cohort study). Int J Clin Pharmacol Ther, 2008 Feb, 46(2): 89-95.

51. Mueller-Lissner S, Kamm MA, Wald A, et al. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation. Am J Gastroenterol, 2010, 105: 897-903.

52. Patankar R, Mishra A. A prospective non-comparative study to assess the effectiveness and safety of combination laxative therapy containing milk of magnesia, liquid paraffin and sodium picosulphate (Cremaffin-Plus®) in the management of constipation in patients with anal fissure/hemorrhoids/obstructive defecation syndrome. Int Surg J, 2017 Dec, 4(12): 3899-3906.

53. Kienzle-Horn S, Vix JM, Schuijt C, Peil H, Jordan CC, Kamm MA. Comparison of bisacodyl and sodium picosulfate in the treatment of chronic constipation. Curr Med Res Opinion, 2007, 23: 891-899.

54. Rossol S. Constipation in patients with diabetes mellitus. MMW Fortschr Med, 2007 Nov 1, 149(44): 39-42.

55. Bengtsson M, Ohlsson B. Psychological wellbeing and symptoms in women with chronic constipation treated with sodium picosulphate. Gastroenterol Nurs, 2005 Jan-Feb, 28(1): 3-12.

56. Wulkow R, Vix JM, Schuijt C, Peil H, Kamm MA, Jordan C. Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation. Int J Clin Pract, 2007 Jun, 61(6): 944-50.


Просмотров: 79


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)